СИНДРОМ АПНОЭ ВО СНЕ И КАРДИОЛОГИЧЕСКАЯ ПАТОЛОГИЯ: СОВРЕМЕННЫЙ ВЗГЛЯД
Аннотация
Обзор посвящён современным данным исследований взаимосвязи синдрома апноэ во время сна и поражений сердечно-сосудистой системы. Рассматриваются различные аспекты данной проблемы, в том числе новые, недавно открытые, механизмы связи апноэ во сне с развитием атеросклероза, ИБС, нарушений ритма сердца. Особое внимание уделено влиянию данного патологического состояния на качество жизни.
Ключевые слова
Об авторах
И. Г. Гордеев
ГБОУ ВПО РНИМУ им. Н. И. Пирогова, лечебный факультет, кафедра госпитальной терапии № 1, Москва
Россия
Россия
д. м.н., профессор, зав. кафедрой госпитальной терапии № 1
О. Ю. Шайдюк
ГБОУ ВПО РНИМУ им. Н. И. Пирогова, лечебный факультет, кафедра госпитальной терапии № 1, Москва
Россия
Россия
к. м.н., доцент кафедры госпитальной терапии № 1
Е. О. Таратухин
ГБОУ ВПО РНИМУ им. Н. И. Пирогова, лечебный факультет, кафедра госпитальной терапии № 1, Москва
Россия
Россия
к. м.н., ассистент кафедры госпитальной терапии № 1
Список литературы
1. Shalnova S. A., Deev A. D. Ischemic Heart Disease in Russia: prevalence and treatment. Terapevticheski arkhiv 2011; 1:7–11. Russian (Шальнова С. А., Деев А. Д. Ишемическая болезнь сердца в России: распространённость и лечение (по данным клинико-эпидемиологических исследований). Терапевтический архив 2011; 1:7–11).
2. Information sheet of the WHO 317 on 09.2011. Official website. Russian (Информационный листок Всемирной организации здравоохранения № 317 от 09.2011. Официальный Интернет-сайт ВОЗ). URL: http://www.who.int/mediacentre/factsheets/fs317/en/index. html (дата обращения 29.09.2012).
3. Heron M. Deaths: leading causes for 2008. Natl Vital Stat Rep 2012;60:1–94.
4. Thornton A. T., Singh P., Ruehland W. R. et al. AASM criteria for scoring respiratory events: interaction between apnea sensor and hypopnea definition. Sleep 2012; 35:425–32.
5. Mokhlesi B., Gozal D. Update in Sleep Medicine 2010. Am J Respir Crit Care Med 2011; 183:1472–6.
6. Mokhlesi B., Gozal D. Adult and Paediatric sleep-disordered breathing. American Thoracic Society 2008; 284p.
7. Salloum A., Rowley J. A., Mateika J. H. et al. Increased propensity for central apnea in patients with obstructive sleep apnea: effect of nasal CPAP. Am J Respir Crit Care Med 2010; 181:189–93.
8. Ayalon L., Ancoli-Israel S., Drummond S. P. Obstructive sleep apnea and age: a double insult to brain function? Am J Respir Crit Care Med 2010; 182:413–9.
9. Menon L., Rudraraju P., Danial V. et al. Prevalence of symptoms of obstructive sleep apnea in patients attending an inner City Primary Care Clinic. Int J Pub Health 2011;1. DOI:10.5580/198a.
10. Somers V. K., White D. P., Amin R. et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 2008; 52 (8):686–717.
11. Wolk R., Kara T., Somers V. K. Sleep-disordered breathing and cardiovascular disease. Circulation 2003; 108 (1):9–12.
12. Kasai T. Sleep apnea and heart failure. J Cardiol 2012; Jul,21.
13. Bakker J. P., Sharma B. et al. Obstructive sleep apnea: an elephant in the cardiovascular room. Chest 2012; 141:580–1.
14. Loke Y. K., Brown J. W., Kwok C. S. et al. Association of OSA with risk of Serious Cardiovascular Events: systematic review and meta-analysis. Circulation CV Outcomes and Quality 2012; Jul, 24.
15. Berger M., Varvarigou V., Rielly A. et al. Employer-mandated sleep apnea screening and diagnosis in commercial drivers. J Occup Environ Med 2012; Jul,30.
16. Koyama R. G., Esteves A. M., Oliveira E. S. et al. Prevalence and risk factors for obstructive sleep apnea syndrome in Brazilian railroad workers. Sleep Med 2012; Jul, 25.
17. Ohayon M. M., Mahowald M. W., Dauvilliers Y. et al. Prevalence and comorbidity of nocturnal wandering in the U. S. adult general population. Neurology 2012; 78 (20):1583–9.
18. Bjoernsdottir E., Janson C., Gislason T. et al. Insomnia in untreated sleep apnea patients compared to controls. J Sleep Res 2012; 21 (2):131–8.
19. Brion A., Flammand M., Oudiette D. et al. Sleep-related eating disorder versus sleepwalking: a controlled study. Sleep Med 2012; Jul,25.
20. Jacobsen J. H., Shi L., Mokhlesi B. et al. Factors associated with excessive daytime sleepiness in patients with severe obstructive sleep apnea. Sleep Breath 2012; Jun,24.
21. Tegelberg A., Nohlert E., Bergman L. E. et al. Bed partners’ and patients’ experiences after treatment of obstructive sleep apnea with an oral appliance. Swed Dent J 2012; 36 (1):35–44.
22. Lal C., Strange C., Bachman D. Neurocognitive impairment in obstructive sleep apnea. Chest 2012; 141 (6):1601–10.
23. Bulcun E., Ekici A., Ekici M. Quality of life and metabolic disorders in patients with obstructive sleep apnea. Clin Invest Med 2012; 35 (2):105–13.
24. Ekici A., Ekici M., Oguztuerck O et al. Personality profiles in patients with obstructive sleep apnea. Sleep Breath 2012; Mar,25.
25. Ferre A., Villa J., Jurado M. J. et al. Sleep-related painful erections associated with obstructive sleep apnea syndrome. Arch Sex Behav 2012; 41 (4):1059–63.
26. Zias N., Bezwada V., Gilman S. et al. Obstructive sleep apnea and erectile dysfunction: still a neglected risk factor? Sleep Breath 2009; 13 (1):3–10.
27. Martin S., Atlantis E., Wilson D. et al. Clinical and biopsychosocial determinants of sexual dysfunction in middle-aged and older australian men. J Sex Med 2012; Jul,3. DOI:10.1111
28. Petersen M., Kristensen E., Berg S. et al. Sexual function in female patients with obstructive sleep apnea. J Sex Med 2011; 8 (9):2560–8.
29. Wheaton A. G., Perry G. S., Chapman D. P. et al. Sleep disordered breathing and depression among U. S. adults: National Health and Nutrition Examination Survey. Sleep 2012; 35 (4):461–7.
30. Ludka O., Konecny T., Somers V. K. Sleep apnea, cardiac arrhythmias and sudden death. Tex Heart Inst J 2011; 38 (4):340–3.
31. Johansson J. K., Kronholm E., Jula A. M. Variability in home-measured blood pressure and heart rate: associations with self-reported insomnia and sleep duration. J Hypertens 2011; 29 (10):1897–1905.
32. Balachandran J. S., Bakker J. P., Rahangdale S. et al. Effect of mild, asymptomatic OSA on daytime heart rate variability and impedance cardiography measurements. J Sleep Res 2012; 21 (3):316–21.
33. Gapelyuk A., Riedi M., Suhrbier A. et al. Cardiovascular regulation in different sleep stages in the obstructive sleep apnea syndrome. Biomed Tech (Berlin) 2011; 56 (4):207–13.
34. Gresova S., Tomori Z., Widdicombe J. et al. Heart rate variability in hypertension caused by sleep disordred breathing and its modification by CPAP. Bratisl Lek Listy 2011; 112 (3):125–30.
35. Kufoy E., Palma J. A., Lopez J. et al. Changes in the heart rate variability in patients with OSA and its response to acute CPAP treatment. PLoS One 2012;7 (3): e33769.
36. Choi J. H., Yi J. S., Lee S. H. et al. Effect of upper airway surgery on heart rate variability in patients with obstructive sleep apnea syndrome. J Sleep Res 2012; 21 (3):316–21.
37. Neves C., Tufik S., Monteiro M. A. et al. The effect of sildenafil on sleep respiratory parameters and heart rate variability in OSA. Sleep Med 2010; 11 (6):545–51.
38. Neves C., Tufik S., Chediek F. et al. Effects of sildenafil on autonomic nervous function during sleep in OSA. Clinics 2010; 65 (4):393–400.
39. Li X., Dong Z., Wan Y. et al. Sildenafil vs CPAP for erectile dysfunction in men with OSA: a meta-analysis. Aging Male 2010; 13 (2):82–86.
40. Voigt L., Haq S. A., Mitre C. A. et al. Effect of OSA on QT dispersion: a potential mechanism of sudden cardic death. Cardiology 2011;118 (1):68–73.
41. Kilicasian F., Tokatli A., Ozdag F. et al. Tp-e interval, Tp-e/QT ratio and Tp-e/QTc ratio a prolonged in patients with moderate and severe OSA. Pacing Clin Electriphysiol 2012; Jun,5. DOI:10.1111.
42. Madias J. E. T-wave alternans in patients with congestive heart failure and sleep apnea. Eur J Heart Fail 2010; 12 (2):208–9.
43. Rossi V. A., Stoewhas A. C., Camen G. et al. The effects of CPAP therapy withdrawal on cardiac repolarization: data from a randomized controlled trial. Eur Heart J 2012; Mar,27.
44. Smith J. H., Baumert M., Nalivaiko E. et al. Arousal in obstructive sleep apnea patients is associated with ECG RR and QT interval shortening and PR interval lengthening. J Sleep Res 2009; 18 (2):188–95.
45. Cicek D., Lakadamyali H., Gokay S. et al. Effect of OSA on heart rate, heart rate recovery and QTc and P-wave dispersion in newly diagnosed untreated patients. Am J Med Sci 2011; Nov, 17.
46. Bitter T., Langer C., Vogt J. et al. Sleep-disordered breathing in patients with atrial fibrillation and normal systolic left ventricular function. Dtsch Arztebl Int 2009; 106:164–70.
47. Kurlykina N. V., Pevzner A. V., Litvin A. Yu. et al. Possibilities of treatment of patients with long nocturnal asystoles and obstructive sleep apnea syndrome by creating constant positive air pressure in upper respiratory tract. Cardiologia 2009; 6:36–42. Russian (Курлыкина Н. В., Певзнер А. В., Литвин А. Ю. и соавт. Возможности лечения больных с длительными ночными асистолиями и синдромом обструктивного апноэ сна созданием постоянного положительного давления воздуха в верхних дыхательных путях. Кардиология 2009; 6:36–42).
48. Maeno K., Kasai A., Setsuda M. et al. Advanced atrioventricular block induced by obstructive sleep apnea before oxygen desaturation. Heart Vessels 2009; 24 (3):236–40.
49. Siebert J., Kowalczuk W., Trzeciak B. et al. Sleep apnea syndrome or atrio-ventricular block and hypertension? Kardiol Pol 2010;68:197–200.
50. Baranchuk A., Parfey B., Lim L. et al. Interatrial block in patients with obstructive sleep apnea. Cardiol J 2011; 18 (2):171–5.
51. Holty J. E., Guilleminault C. Sleep-related bradyarrhythmia syndrome. Sleep Med Rev 2011; 15 (3):143–51.
52. Kawana F., Kasai T., Maeno K. et al. AV-block during the phasic events of REM sleep in a patient with severe obstructive sleep apnea syndrome. J Clin Sleep Med 2008; 4 (3):257–9.
53. Wang H., Zhang X. L., Cai Y. Y. et al. Association between severe OSA syndrome and sinus dysfunction. Zhonghua Yi Xue Za Zhi 2007; 21:87:2185–8.
54. Serafini A., Dolso P., Gigli G. L. et al. REM-sleep bradyarrhythmias: an indication to pacemaker implantation? Sleep Med 2012; 13 (6):759–62.
55. Cioffi G., Russo T. E., Selmi A. et al. Analysis of left ventricular systolic function by midwall mechanics in patients with obstructive speep apnea. Eur J Echocardiogr 2011; 12 (1):61–8.
56. Usui Y., Takata Y., Innoue Y. et al. Coexistence of OSA and metabolic syndrome is independently associated with left ventricular hypertrophy and diastolic dysfunction. Sleep Breath 2011; Jul21.
57. Varol E., Akcay S., Ozaydin M. et al. Influence of OSA on left ventricular mass and global function: sleep apnea and myocardial performance index//Heart Vessels. 2010; 25 (5):400–4.
58. Moro J. A., Almenar L., Ponce S. et al. Silent heart disease in patinets with sleep apnea-hypopnea syndrome: usefulness of the myocardial performance index. Arch Bronchopneumol. 2008; 44 (8):418–23.
59. Chami H. A., Devereux R. B., Gottdiener J. S. et al. Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study. Circulation 2008; 117:2599–607.
60. Usui Y., Tomiyama H., Hashimoto T. et al. Plasma B-type natriuretic peptide level is associated with left ventricular hypertrophy among OSA patients. J Hypertens 2008; 26 (1):117–23.
61. Steiner S., Schueller P. O., Hennersdorf M. G. et al. Impact of OSA on the occurence of restenosis after elective PCI in ischemic heart disease. Respir Res 2008; 9:50.
62. Meng S., Fang L., Wang C. Q. et al. Impact of OSA on clinical characteristics and outcomes in patients with acute coronary syndrome following PCI. J Int Med Res 2009; 37 (5):1343–53.
63. Hrynkiewicz-Szymanska A., Szymanski F. M., Filipiak K. J. et al. Can obstructive sleep apnea be a cause of in-stent thrombosis? Sleep Breath 2011; 15 (3):607–9.
64. Ozeke O., Gungor M., Ertan C. et al. Association of sleep apnea with coronary slow-flow phenomenon. J Cardiovasc Med 2012; 13 (6):376–80.
65. Damy T., Margarit L., Noroc A. et al. Prognostic impact of sleep-disordered breathing and its treatment with nocturnal ventilation for CHF. Eur J Heart Fail 2012; Jun, 22.
66. Altintas N., Aslan E., Helvaci A. et al. Relationship between OSA severity index and left ventricular function and volume. Ann Saudi Med 2012; 32 (4):384–90.
67. Kasai T. Sleep apnea and heart failure. J Cardiol 2012; Jul,21.
68. Khayat R., Abraham W., Patt B. et al. Central Sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure. J Card Fail 2012; 18 (7):534–40.
69. Knecht K. M., Alosco M. L., Spitznagel M. B. et al. Sleep apnea and cognitive function in heart failure. Cardiovasc Psych Neurol 2012; 2012:402079.
70. Yumino D., Redolfi S., Su M. C. et al. Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 2010;121:1598–605.
71. Bradley T. D., Floras J. S. Sleep apnea and heart failure: Part I. Carculation 2003; 107 (12):1671–8.
72. Bradley T. D., Floras J. S. Sleep apnea and heart failure: Part II. Carculation 2003; 107 (13):1822–7.
73. Ozeke O., Etan C., Demir A. D. Sleep apnea, heart failure and sleep position. Sleep Breath 2011; Nov, 9.
74. Wan Z. H., Wen F. J., Hu K. Dynamic CO (2) inhalation: a novel treatment for CSA associated with CHF. Sleep Breath 2012; May, 24.
75. Momomura S. Treatment of CSR in patients with central sleep apnea. J Cardiol 2012; 59:110–6.
76. Augostini R. A novel approach to the treatment of CSA in patients with heart failure. Herzschrittmaherther Elektrophysiol 2012; 23 (1):9–13.
77. Campbell A. L., Ferrier K., Neill A. M. The effect of oxygen vs adaptive pressure support servo-ventillation in patients with central sleep apnea and congestive heart failure. Intern Med J 2011; Oct, 27.
78. Javaheri S., Shukla R., Wexler L. Association of smoking, sleep apnea and plasma alkalosis with nocturnal ventricular arrhythmias in men with systolic heart failure. Chest 2012; 141 (6):1449–56.
79. Ozsu S., Abul Y., Gulsoy A. et al. Red cell distribution width in patients with OSA syndrome Lung 2012; 190 (3):319–26.
80. Jimenez J. A., Greenberg B. H., Mills P. J. Effects of heart failure and its pharmacological management on sleep. Drug Discov Today Dis Models 2011; 8 (4):161–6.
81. Kasai T., Arcand J., Allard J. P. et al. Relationship between sodium intake and sleep apnea in patients with heart failure. J Am Coll Cardiol 2011; 58:1970–4.
82. Luyster F. S., Kip K. E., Drumheller O. J. et al. Sleep apnea is related to the aterogenic phenotype, LP subclass B. J Clin Sleep Med 2012; 8 (2):155–61.
83. Togeiro S. M., Carneiro G., Flho F. F. et al. Consequences of OSA on metabolic profile: a population-based survey. Obesity 2012; Jun,14.
84. Okur H. K., Pelin Z., Yuksel M. et al. Lipid peroxidation and paraoxonase activity in nocturnal cyclic and sustained intermittent hypoxia. Sleep Breath 2012; Apr,18.
85. Sovova E., Hobzova M., Stejskal D. et al. Treatment of OSA with CPAP decreases adipocyte fatty acid-binding protein levels. Biomed Pap Med Fac 2012; 156 (1):58–62.
86. Monneret D., Tamisier R., Ducros V. et al. The impact of OSA on homocysteine and carotid remodeling in metabolic syndrome. Respir Physiol Neurobiol 2012; 180:298–304.
87. Ladeisch J. B., Pottala J. V., Romaker A. et al. Membrane level of omega-3 acid is associated with severity of OSA. J Clin Sleep Med 2011; 7 (4):391–6.
88. Jun J. C., Drager L. F., Najjar S. S. et al. Effects of sleep apmea on nocturnal free fatty acids in subjects with heart failure. Sleep 2011; 34 (9):1207–13.
89. Kawano Y., Tamura A., Kadota J. Asssociation between the severity of OSA and the ratio of LDP cholesterol to HDL cholesterol. Metabolism 2012; 61 (2):186–92.
90. Drager L. F., Polotsky V. Y., Lorenzi-Filho G. OSA: an emerging risk factor for atherosclerosis Chest 2011; 140 (2):534–42.
91. Guo Y., Pan L., Ren D. et al. Impact of CPAP on C-reactive protein in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath 2012; Jun, 5.
92. Carpagnano G. E., Foschino-Barbaro M. P., Carrtu P. et al. Could neutrophilic airway inflammation in obese people be more due to obstructive sleep apnea syndrome than to asthma? Eur Respir J 2012; 39 (6):1547–9.
93. Kang J. H., Lin H. C. Obstructive sleep apnea and the risk of autoimmune diseases: a longitudinal population-based study. Sleep Med 2012; 13 (6):583–6.
94. Kunz A. B., Kraus J., Young P. et al. Biomarkers of inflammation and endothelial dysfunction in stroke with and without sleep apnea. Cerebrovasc Dis 2012; 33 (5):453–60.
95. Qian X., Yin T., Li T. et al. High levels of inflammation and insulin resistance in OSA patients with hypertension. Inflammation 2012; 35 (4):1507–11.
96. Lavie L. Oxidative stress inflammation and endothelial dysfunction in obstructive sleep apnea. Front Biosci (Elite Ed.) 2012; 4:1391–403.
97. Ntalapascha M., Makris D., Kyparos A. et al. Oxidative stress in patients with OSA syndrome. Sleep Breath 2012; May,18.
98. Mancuso M., Bonanni E., LoGerfo A. et al. Oxidative stress biomarkers in patients with untreated OSA syndrome. Sleep Med 2012; 13 (6):632–6.
99. Akinnusi M. E., Laporta R., El-Solh A. A. et al. Lectin-like oxidized lowdensity lipoprotein receptor-1 modulates endothelial apoptosis in OSA. Chest 2011; 140 (6):1503–10.
100. Lui M. M., Lam D. C., Ip M. S. Significance of endothelial dysfunction in sleep-disordered breathing. Respirology 2012; Jun,19.
101. Guo Q., Wang Y., Li Q. Y. et al. Levels of thioredoxin are related to the severity of obstructive sleep apnea: based on oxidative stress concept. Sleep Breath 2012; Mar,22.
102. Hira H. S., Shukla A., Kaur A. et al. Serum uric acid and lactate levels among patients with OSA syndrome. Ann Saudi Med 2012; 32 (1):37–42.
103. Liak C., Fitzpatrick M. Coagulability in sleep apnea. Can Respir J 2011; 18 (6):338–48.
104. Toukh M., Pereira E. J., Falcon B. J. et al. CPAP reduces hypercoagulability as assessed by thromboelastography in severe obstructive sleep apnea. Respir Physiol Neurobiol 2012; 183 (3):218–23.
105. Mehra R., Xu F., Babineau D. C. et al. Sleep-disordered breathing and prothrombotic biomarkers: cross-sectional results of the Cleveland Family Study. Am J Respir Crit Care Med 2010; 182 (6):826–33.
106. Maruyama K., Morishita E., Sekiya A. et al. Plasma levels of platelet-derived microparticles in patients with obstructive sleep apnea syndrome. J Atheroscler Thromb 2012; 19 (1):98–104.
107. Nena E., Papana N., Steiropoulos P. et al. Mean platelet volume and platelet distribution width in non-diabetic subjects with OSA syndrome: new indices of severity? Platelets 2011; Nov,10.
108. Varol E., Ozturk O., Gonca T. et al. Mean platelet volume is increased in patients with severe OSA. Scand J Clin Lab Invest 2010; 70 (7):497–502.
109. Kondo Y., Kuwahira I., Shimizu M. et al. Significant relationship between platelet activation and apnea-hypopnea index in patients with OSA syndrome. Tokai J Exp Clin Med 2011; 36:79–83.
110. Peker Y. Platelet activity and cardiovascular risk in obesity and obstructive sleep apnea. J Clin Sleep Med 2011; 7:172–8.
111. Barcelo A., Pierola J., de la Pena M. et al. Impaired circadian variation of platelet activity in patients with sleep apnea. Sleep Breath 2012; 16 (2):355–60.
112. Oga T., Chin K., Tabuchi A. et al. Effects of OSA with intermittent hypoxia on platelet aggregability. J Atheroscler Thromb 2009; 16:862–9.
113. Phillips C. L., McEwen B. J., Morel-Kopp M. C. et al. Effects of CPAP on coagulability in OSA: a randomized placebo-controlled crossover study. Thorax 2012; 67:639–44.
Рецензия
Для цитирования:
Гордеев И.Г., Шайдюк О.Ю., Таратухин Е.О. СИНДРОМ АПНОЭ ВО СНЕ И КАРДИОЛОГИЧЕСКАЯ ПАТОЛОГИЯ: СОВРЕМЕННЫЙ ВЗГЛЯД. Российский кардиологический журнал. 2012;(6):5-12.
For citation:
Gordeev I.G., Shaydyuk O.Yu., Taratukhin E.O. SLEEP APNOEA SYNDROME AND CARDIOVASCULAR DISEASE: A MODERN VIEW. Russian Journal of Cardiology. 2012;(6):5-12. (In Russ.)
Просмотров:
484
Послать статью по эл. почте 